Daniel A. Rubé, Ph.D., Attorney, Troutman Sanders LLP to Speak at Patent Protection for Pharma and Biotechnology in 2020 LIVE Webcast
The Knowledge Group, the leading producer of regulatory focused webcasts, has announced today that Daniel A. Rubé, Ph.D., Attorney, Troutman Sanders LLP will speak at the Knowledge Group’s webcast entitled: “Patent Protection for Pharma and Biotechnology in 2020 LIVE Webcast.”
- (1888PressRelease) April 20, 2020 - This event is scheduled for Thursday, April 23, 2020 from 3:00PM to 4:30PM ET.
For further details, please visit:
https://www.theknowledgegroup.org/webcasts/pharma-and-biotechnology-in-2020/
About Daniel A. Rubé, Ph.D.
Dr. Daniel Rubé has practiced intellectual property law for over ten years, focusing primarily on patent prosecution and due diligence. He studied chemistry at the State University of New York at Buffalo, and received a Ph.D. in biological chemistry at UCLA. He has a law degree from Stanford. His research experience is in cell biology, molecular biology, genetics and biochemistry. Daniel finds science fun and interesting, and likes challenges with cutting edge technology. His patent experience includes these areas as well as immunology, DNA sequencing, pharmaceutical and cosmetic formulations, polymers, and materials science. He serves large companies, startups, universities, research institutes and solo inventors.
About Troutman Sanders LLP
Troutman Sanders has four core practices—Transactional, Business Litigation, Specialized Litigation, and Regulatory & Finance, under which it boasts 16 sections, including intellectual property law. For Troutman Sanders, practicing law is about commitment, with a “higher commitment to client care” being one of the most important values that differentiates Troutman Sanders from other law firms. In recognition of Troutman’s strong client service culture, the firm has been on the BTI Client Service A-Team for 13 consecutive years. Troutman develops and implements global protection and commercialization strategies for clients with intellectual property assets in virtually all industry areas. Many of Troutman’s attorneys and professionals have Ph.D.s and other advanced technical degrees in a wide variety of disciplines, and enjoyed successful careers as inventors, researchers, engineers, physicians and scientists prior to joining the firm.
Abstract
Pharmaceutical and biotechnology patents have increased aggressively in recent years. Consequently, this upward trend has posed a greater risk for the U.S. pharma patents. Political and economic troubles such as claims of patent evergreening abuse have also added complexity on existing challenges.
As biopharma innovators face this troubled landscape, effective IP protection strategies have become more imperative. Current and future plans must be carefully weaved to properly address legal challenges.
In this LIVE Webcast, a seasoned panel of thought leaders and professionals brought together by The Knowledge Group will provide the audience with an in-depth analysis of the fundamentals as well as recent developments in pharma and biotechnology patent. Speakers will also present helpful tips on how companies and patent owners can strengthen their strategies to overcome significant hurdles.
Key topics include:
• Trends and Developments in U.S. Pharma and Biotechnology Patents
• Current and Emerging Challenges Faced by Patent Owners
• Notable Cases
• Best Practices and Helpful Tips
• Outlook
About The Knowledge Group
The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register to an event, please visit: http://theknowledgegroup.org/.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam